Allakos Inc. (ALLK) Financial Statements (2025 and earlier)

Company Profile

Business Address 825 INDUSTRIAL ROAD
SAN CARLOS, CA 94070
State of Incorp. DE
Fiscal Year End December 31
Industry (SIC) 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete Financial Analysis Financial Benchmarking

Balance Sheet (Statement of Financial Position) (USD)

12/31/2024
12/31/2023
12/31/2022
12/31/2021
12/31/2020
12/31/2019
12/31/2018
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments, including:170,800,000279,800,000424,200,000659,000,000495,900,000178,900,000
Cash and cash equivalent66,440,00087,217,000152,822,000207,177,00038,367,00033,660,000
Short-term investments104,354,000192,569,000271,416,000451,820,000457,534,000145,246,000
Other undisclosed cash, cash equivalents, and short-term investments6,00014,000(38,000)3,000(1,000)(6,000)
Restricted cash and investments      
Prepaid expense1,092,0001,741,000    
Other undisclosed current assets7,997,00027,302,00027,381,00010,267,0003,970,0002,709,000
Total current assets:179,889,000308,843,000451,581,000669,267,000499,870,000181,609,000
Noncurrent Assets
Operating lease, right-of-use asset 24,136,00030,225,00031,707,00039,731,0005,775,000
Property, plant and equipment33,369,00039,144,00043,100,0008,345,0008,410,0008,848,000
Other noncurrent assets6,216,0008,208,0008,436,0002,275,0002,839,000802,000
Total noncurrent assets:63,721,00077,577,00083,243,00050,351,00017,024,0009,650,000
TOTAL ASSETS:243,610,000386,420,000534,824,000719,618,000516,894,000191,259,000
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities36,578,00030,038,00040,249,00022,450,00013,061,0005,256,000
Accounts payable1,764,0004,832,00013,692,00013,960,0005,963,0002,092,000
Accrued liabilities34,814,00025,206,00026,557,0008,490,0007,098,0003,164,000
Total current liabilities:36,578,00030,038,00040,249,00022,450,00013,061,0005,256,000
Noncurrent Liabilities
Long-term debt and lease obligation:   49,099,00042,773,000  
Liabilities, other than long-term debt 38,215,00045,949,000  8,112,0002,009,000
Other liabilities     8,112,0002,009,000
Operating lease, liability 38,215,00045,949,00049,099,00042,773,000 
Other undisclosed noncurrent liabilities   (49,099,000)(42,773,000)  
Total noncurrent liabilities: 38,215,00045,949,00049,099,00042,773,0008,112,0002,009,000
Total liabilities:74,793,00075,987,00089,348,00065,223,00021,173,0007,265,000
Equity
Equity, attributable to parent168,817,000310,433,000445,476,000654,395,000495,721,000183,994,000
Common stock88,00085,00054,00053,00048,00042,000
Additional paid in capital1,287,156,0001,243,408,0001,058,399,000997,298,000685,020,000288,079,000
Accumulated other comprehensive income (loss)50,000(284,000)(153,000)8,000137,000(15,000)
Accumulated deficit(1,118,477,000)(932,776,000)(612,824,000)(342,964,000)(189,484,000)(104,112,000)
Total equity:168,817,000310,433,000445,476,000654,395,000495,721,000183,994,000
TOTAL LIABILITIES AND EQUITY:243,610,000386,420,000534,824,000719,618,000516,894,000191,259,000

Income Statement (P&L) (USD)

12/31/2024
12/31/2023
12/31/2022
12/31/2021
12/31/2020
12/31/2019
12/31/2018
Operating expenses(196,056,000)(322,429,000)(271,475,000)(157,057,000)(91,418,000)(45,721,000)
Operating loss:(196,056,000)(322,429,000)(271,475,000)(157,057,000)(91,418,000)(45,721,000)
Nonoperating income (expense)
(Other Nonoperating Income (Expense))
8,000(1,196,000)1,238,000(736,000)(155,000)(192,000)
Loss from continuing operations before equity method investments, income taxes:(196,048,000)(323,625,000)(270,237,000)(157,793,000)(91,573,000)(45,913,000)
Other undisclosed income from continuing operations before income taxes     6,201,0002,375,000
Loss from continuing operations:(196,048,000)(323,625,000)(270,237,000)(157,793,000)(85,372,000)(43,538,000)
Loss before gain (loss) on sale of properties:(270,237,000)(157,793,000)(85,372,000)(43,538,000)
Other undisclosed net income    4,313,000  
Net loss:(196,048,000)(323,625,000)(270,237,000)(153,480,000)(85,372,000)(43,538,000)
Other undisclosed net income attributable to parent10,347,0003,673,000377,000   
Net loss available to common stockholders, diluted:(185,701,000)(319,952,000)(269,860,000)(153,480,000)(85,372,000)(43,538,000)

Comprehensive Income (USD)

12/31/2024
12/31/2023
12/31/2022
12/31/2021
12/31/2020
12/31/2019
12/31/2018
Net loss:(196,048,000)(323,625,000)(270,237,000)(153,480,000)(85,372,000)(43,538,000)
Comprehensive loss:(196,048,000)(323,625,000)(270,237,000)(153,480,000)(85,372,000)(43,538,000)
Other undisclosed comprehensive income (loss), net of tax, attributable to parent10,681,0003,542,000216,000(129,000)152,000(15,000)
Comprehensive loss, net of tax, attributable to parent:(185,367,000)(320,083,000)(270,021,000)(153,609,000)(85,220,000)(43,553,000)

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: